SCHEMBL6159814

SCHEMBL6159814

COc1ccc(CN2CCN(c3ccc(Cc4ccc(F)cc4)cc3)CC2)c(OC)c1OC

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.88
SMN1; SMN2 Q16637 1/20 0.88
CHRM2 P08172 2/20 0.61
OPRK1 P41145 2/20 0.61
ADORA3 P0DMS8 1/20 0.61
CHRM1 P11229 1/20 0.61
DRD2 P14416 1/20 0.61
ADRA2B P18089 1/20 0.61
ADRA2C P18825 1/20 0.61
CNR1 P21554 1/20 0.61
SLC6A2 P23975 1/20 0.61
HTR2A P28223 1/20 0.61
HTR2C P28335 1/20 0.61
ADRA1A P35348 1/20 0.61
HRH1 P35367 1/20 0.61
OPRM1 P35372 1/20 0.61
DRD3 P35462 1/20 0.61
HTR2B P41595 1/20 0.61
HTT P42858 1/20 0.61
CACNA1B Q00975 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28298203 0.79 CHRM2 (0.79) LMNASMN1; SMN2CHRM2OPRK1ADORA3
SCHEMBL11180195 0.78 LMNA (0.67) LMNASMN1; SMN2DRD2DRD3HTT
SCHEMBL6160982 0.78 LMNA (0.70) LMNASMN1; SMN2CHRM2OPRK1HTT
Hydrochloric Acid SCHEMBL11181657 0.77 LMNA (0.65) LMNASMN1; SMN2DRD2DRD3HTT
SCHEMBL18177904 0.76 MEN1 (0.70) LMNASMN1; SMN2CHRM2OPRK1ADORA3
Lomerizine SCHEMBL79390 0.76 LMNA (1.00) LMNASMN1; SMN2CHRM2OPRK1ADORA3
Lomerizine SCHEMBL29496366 0.76 LMNA (1.00) LMNASMN1; SMN2CHRM2OPRK1ADORA3
SCHEMBL6159816 0.76 LMNA (0.67) LMNASMN1; SMN2CHRM2OPRK1ADORA3
Lomerizine SCHEMBL1153647 0.75 LMNA (0.98) LMNASMN1; SMN2CHRM2OPRK1ADORA3
Lomerizine SCHEMBL29439945 0.75 LMNA (0.98) LMNASMN1; SMN2CHRM2OPRK1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
US-6048876-A ANTICONVULSANTS; ANTIEPILEPIC AGENT SUNTORY LIMITED (JP) 2000-04-11 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed